The Italian multicenter experience with edaravone in amyotrophic lateral sclerosis-Reference-Cited by-同舟云学术

The Italian multicenter experience with edaravone in amyotrophic lateral sclerosis

Published:2020-06-17 Issue:11 Volume:267 Page:3258-3267
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Lunetta Christian,Moglia Cristina,Lizio Andrea,Caponnetto Claudia,Dubbioso Raffaele,Giannini Fabio,Matà Sabrina,Mazzini Letizia,Sabatelli Mario,Siciliano Gabriele,Simone Isabella Laura,Sorarù Gianni,Toriello Antonella,Trojsi Francesca,Vedovello Marcella,D’Ovidio Fabrizio,Filippi Massimo,Calvo Andrea^ORCID,

Publisher

Springer Science and Business Media LLC

Subject

Clinical Neurology,Neurology

Link

https://link.springer.com/content/pdf/10.1007/s00415-020-09993-z.pdf

Reference10 articles.

1. Abe K, Itoyama Y et al (2014) Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of Edaravone (MCI-186) in amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler Frontotemporal Degener 15:610–617

2. Edaravone (MCI-186) ALS 16 Study Group (2017) A post-hoc subgroup analysis of outcomes in the first phase III clinical study of edaravone (MCI-186) in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 18:11–19

3. Akimoto M, Nakamura K, Writing Group on behalf of the Edaravone (MCI-186) ALS 19 Study Group ( 2017) Edaravone for treatment of early-stage ALS. Lancet Neurol 16:772

4. Al-Chalabi A, Andersen PM et al (2017) ENCALS statement on edaravone. Amyotroph Lateral Scler Frontotemporal Degener 18:471–474

5. Atassi N, Berry J, Shui A, Zach N, Sherman A, Sinani E et al (2014) The PRO-ACT database: design, initial analyses, and predictive features. Neurology 83:1719–1725

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium Phenylbutyrate and Tauroursodeoxycholic Acid: A Story of Hope Turned to Disappointment in Amyotrophic Lateral Sclerosis Treatment;Clinical Drug Investigation;2024-06-23

2. The Endocannabinoid System as a Potential Therapeutic Target for Amyotrophic Lateral Sclerosis;Motor Neurons - New Insights;2024-06-19

3. Introductory Chapter: Motor Neurons – New Insights;Motor Neurons - New Insights;2024-06-19

4. Update on recent advances in amyotrophic lateral sclerosis;Journal of Neurology;2024-05-27

5. Glycolic acid and D-lactate—putative products of DJ-1—restore neurodegeneration in FUS - and SOD1-ALS;Life Science Alliance;2024-05-17